YOUR BUSINESS AUTHORITY
Springfield, MO
Merck & Co. has agreed to acquire Cidara Therapeutics Inc. in a deal valued at $9.2 billion.
Bloomberg reports the deal is part of Merck & Co.'s ongoing efforts to make up for an upcoming patent loss of cancer drug Keytruda.
Cidara is a biotech company developing a flu treatment.
Read more from Bloomberg.
Project work in Springfield corridor will continue into 2031.
Thanksgiving staple recalled at Costco
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
HBA of Greater Springfield executive officer to retire
Transportation officials discuss $471M Forward 44 initiative
Monday Morning Business Leads: Nov. 16, 2026
Former OMB Bank officer placed on probation
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.